HeartBeat.bio and Cubase Bio partner to advance 3D spatial transcriptomics for cardiovascular drug discovery

HeartBeat.bio AG, a TechBio company developing a human cardiac organoid-based drug discovery platform, and Cubase Bio, a genomics company developing true 3D spatial transcriptomics technologies, announced a strategic research collaboration to advance spatial profiling of human cardiac organoids for ...